Venetoclax in Combination with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Single-Centre Experience

被引：1
|
作者：
Piccini, Matteo [1 ]
Pilerci, Sofia [2 ]
Scappini, Barbara [2 ]
Mannelli, Francesco [3 ]
Ciolli, Gaia [4 ]
Pasquini, Andrea [4 ]
Fasano, Laura [4 ]
Quinti, Elisa [4 ]
Guglielmelli, Paola [5 ]
Mannarelli, Carmela [5 ]
Pancani, Fabiana [5 ]
Zizza, Michela [5 ]
Signori, Leonardo [5 ]
Vannucchi, Alessandro M. [6 ]
Gianfaldoni, Giacomo [2 ]
机构：
[1] Univ Firenze, AOU Careggi, SOD Ematol, Florence, Italy
[2] Azienda Osped Univ Careggi, SOD Ematol, Florence, Italy
[3] Azienda Osped Univ Careggi, CRIMM Ctr Res & Innovat Myeloproliferat Neoplasms, SOD Ematol, Florence, Italy
[4] Univ Firenze, Azienda Osped Univ Careggi, Scuola Specializzaz Ematol, SOD Ematol, Florence, Italy
[5] Univ Florence, Ctr Res & Innovat Myeloproliferat Neoplasms, AOU Careggi, CRIMM, Florence, Italy
[6] Univ Firenze, CRIMM Ctr Ric & Innovaz Malattie Mieloproliferat, Azienda Osped Univ Careggi, Florence, Italy
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163212
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
615
引用
收藏
页码：9008 / 9009
页数：2
相关论文
共 50 条
  • [1] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
  • [2] Venetoclax with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting
    Piccini, Matteo
    Pilerci, Sofia
    Scappini, Barbara
    Bencini, Sara
    Peruzzi, Benedetta
    Caporale, Roberto
    Signori, Leonardo
    Fabiana, Pancani
    Maria, Vannucchi Alessandro
    Gianfaldoni, Giacomo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S289 - S289
  • [3] Venetoclax plus Cladribine plus Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax plus Hypomethylating Agent
    Steinauer, Nickolas
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Mangaonkar, Abhishek A.
    Saliba, Antoine
    Hefazi, Mehrdad
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Pardanani, Animesh D.
    Badar, Talha
    Murthy, Hemant S.
    Foran, James M.
    Yi, Cecilia Y. Arana
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2023, 142
  • [4] Combination of Venetoclax and Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: Single-Center Clinical Experience
    Secilmis, Sema
    Bozan, Ersin
    Darcin, Tahir
    Yaman, Samet
    Yigenoglu, Tugcenur
    Ulu, Bahar Uncu
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Yildiz, Jale
    Baysal, Nuran Ahu
    Iskender, Dicle
    Cakar, Merih Kizil
    Sinan, Dal Mehmet
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S192 - S193
  • [5] Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
    Aldoss, Ibrahim
    Yang, Dongyun
    Aribi, Ahmed
    Ali, Haris
    Sandhu, Karamjeet
    Al Malki, Monzr M.
    Mei, Matthew
    Salhotra, Amandeep
    Khaled, Samer
    Nakamura, Ryotaro
    Snyder, David
    O'Donnell, Margaret
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    HAEMATOLOGICA, 2018, 103 (09) : E404 - E407
  • [6] VENETOCLAX AND HYPOMETHYLATING AGENTS IN ACUTE MYELOID LEUKAEMIA: A SINGLE-CENTRE EXPERIENCE
    Dreisinger, M.
    Roskar, Z.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S54 - S54
  • [7] Venetoclax in Combination With Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia: Clinical Experience From a Real-Life Setting
    Piccini, Matteo
    Gianfaldoni, Giacomo
    Mannelli, Francesco
    Scappini, Barbara
    Ciolli, Gaia
    Pasquini, Andrea
    Fasano, Laura
    Pilerci, Sofia
    Quinti, Elisa
    Crupi, Francesca
    Guglielmelli, Paola
    Vannucchi, Alessandro Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S285 - S286
  • [8] Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis
    Bewersdorf, Jan Philipp
    Giri, Smith
    Wang, Rong
    Williams, Robert T.
    Tallman, Martin S.
    Zeidan, Amer M.
    Stahl, Maximilian
    HAEMATOLOGICA, 2020, 105 (11) : 2659 - 2663
  • [9] Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
    Ferrara, Felicetto
    BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [10] Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
    Felicetto Ferrara
    Blood Cancer Journal, 10
12345